跳至主要内容
临床试验/NCT06564961
NCT06564961已完成3 期

The Effect of Clomiphene Citrate on Sperm Parameters in Infertile Men With Idiopathic Oligoasthenozoospermia

Shakeela Ishrat1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年7月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Change from baseline in sperm motility at 12 weeks

研究概览

简要总结

The goal of this clinical trial is to learn if drug clomiphene citrate improves sperm parameters in infertile men with idiopathic oligoasthenozoospermia. It will also learn about the safety of clomiphene citrate. The main questions it aims to answer are:

  • Does drug clomiphene citrate change sperm count and motility in infertile men with idiopathic oligoasthenozoospermia?
  • What medical problems do participants have when taking drug clomiphene citrate? Researchers will compare drug clomiphene citrate to a placebo (a look-alike substance that contains no drug) to see if drug clomiphene citrate works to treat idiopathic oligoasthenozoospermia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Placebo

入排标准

年龄范围
25 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Infertile men
  • Idiopathic oligoasthenozoospermia (serum FSH and serum LH range was 2-7 IU/mL and serum testosterone level was >300 ng/dl)

排除标准

  • Azoospermia
  • Body mass index <18 kg/m2 and >30 kg/m2
  • Any abnormality on genital examination and scrotal sonogram
  • History of genital diseases & genital surgery
  • Medical and endocrine disorders like uncontrolled diabetes mellitus, severe kidney disease and liver insufficiency
  • Psycho-sexual abnormalities
  • Antioxidant supplements in previous 3 months
  • Smoking, drug, alcohol or substance abuse
  • History of chemotherapy or radiotherapy
  • Presence of any gross female factor abnormality

研究组 & 干预措施

Clomiphene

Experimental

Participants will receive Tab Clomiphene citrate 50 mg orally once daily or 12 weeks

干预措施: Clomiphene Citrate (Drug)

Placebo

Placebo Comparator

Participants will receive Clomiphene citrate placebo tablet matching Clomiphene citrate orally once daily for 12 weeks

干预措施: Placebo (Drug)

结局指标

主要结局

Change from baseline in sperm motility at 12 weeks

时间窗: Baseline and 12 weeks

Sperm motility was percentage of progressive \& non-progressive motility

Change from baseline in sperm count at 12 weeks

时间窗: Baseline and 12 weeks

Sperm count was in million per milliliter of semen

次要结局

未报告次要终点

研究者

发起方
Shakeela Ishrat
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Shakeela Ishrat

Professor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

研究点 (1)

Loading locations...

相似试验